In addition, the effects of MAPK3/1 (ERK1/2) hyperactivation in EDMD-related DCM in a mouse model have been confirmed using a germline deletion of MAPK3/ERK1 [72]. This evidence concerns the gene MAPK3 and Emery-Dreifuss muscular dystrophy.